Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...